0001209191-11-031209.txt : 20110526 0001209191-11-031209.hdr.sgml : 20110526 20110526155513 ACCESSION NUMBER: 0001209191-11-031209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110525 FILED AS OF DATE: 20110526 DATE AS OF CHANGE: 20110526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Emmens Matthew CENTRAL INDEX KEY: 0001298332 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 11874042 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST., ATTN: GENERAL COUNSEL CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-05-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001298332 Emmens Matthew C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 0 1 0 0 CEO & President Common Stock 2011-05-25 4 S 0 9735 55.51 D 220400 D Open market sales reported on this line occurred at a weighted average price of $55.51 (range $55.27 to $55.66). Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Kenneth S. Boger, Attorney-In-Fact 2011-05-26